S2 Fig contains incorrectly duplicated panels. The authors have provided a corrected version here.
Supporting information
Hematoxylin and eosin staining of TA tissue sections from treated C57BL6 mice with 2 μg PMO, 5 μg PNA and 5 μg 2′Ome PS by local injection at different time-points e.g. 48 hr, 2 and 4 weeks after injection, and C57BL6 normal controls. Scale Bar = 100 μm. No difference was observed between treated and untreated mdx mice.
(TIF)
Reference
- 1.Cao L, Han G, Gu B, Yin H (2014) Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy. PLoS ONE 9(11): e111079 10.1371/journal.pone.0111079 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Hematoxylin and eosin staining of TA tissue sections from treated C57BL6 mice with 2 μg PMO, 5 μg PNA and 5 μg 2′Ome PS by local injection at different time-points e.g. 48 hr, 2 and 4 weeks after injection, and C57BL6 normal controls. Scale Bar = 100 μm. No difference was observed between treated and untreated mdx mice.
(TIF)